AnnJi Pharmaceutical Announced Licensing Agreement With Avenue...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TAIPEI, March 14, 2023 /PRNewswire-AsiaNet/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel...
Authors: LATEST ASIANET NEWS RELEASES